2,109
Views
3
CrossRef citations to date
0
Altmetric
Editorial

The potential of natural sources for pancreatic lipase inhibitors: a solution of the obesity crisis?

, , , &
Pages 1295-1298 | Received 05 Jun 2022, Accepted 05 Dec 2022, Published online: 12 Dec 2022

References

  • Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol (Lausanne). 2021;12:706978.
  • Stuby J, Gravestock I, Wolfram E, et al. Appetite-suppressing and satiety-increasing bioactive phytochemicals: a systematic review. Nutrients. 2019;11(9):2238.
  • Weibel EK, Hadvary P, Hochuli E, et al. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. J Antibiot (Tokyo). 1987;40(8):1081–1085.
  • Shamarao N, Chethankumar M. Antiobesity drug-likeness properties and pancreatic lipase inhibition of a novel low molecular weight lutein oxidized product, LOP6. Food Funct. 2022;13(11):6036–6055.
  • Liu H, Liu M, Jin Z, et al. Ginsenoside Rg2 inhibits adipogenesis in 3T3-L1 preadipocytes and suppresses obesity in high-fat-diet-induced obese mice through the AMPK pathway. Food Funct. 2019;10(6):3603–3614.
  • Olennikov DN, Chirikova NK, Vasilieva AG, et al. LC-MS profile, gastrointestinal and gut microbiota stability and antioxidant activity of rhodiola rosea herb metabolites: a comparative study with subterranean organs. Antioxidants (Basel). 2020;9(6):526.
  • Chen X, Xue S, Lin Y, et al. Immobilization of porcine pancreatic lipase onto a metal-organic framework, PPL@MOF: a new platform for efficient ligand discovery from natural herbs. Anal Chim Acta. 2020;1099:94–102.
  • L-J M, Hou X-D, Qin X-Y, et al. Discovery of human pancreatic lipase inhibitors from root of Rhodiola Crenulata via integrating bioactivity-guided fractionation, chemical profiling and biochemical assay. J Pharm Anal. 2022;12(4):683–691.
  • Rajan L, Palaniswamy D, Mohankumar SK. Targeting obesity with plant-derived pancreatic lipase inhibitors: a comprehensive review. Pharmacol Res. 2020;155:104681.
  • Hou XD, Guan XQ, Cao YF, et al. Inhibition of pancreatic lipase by the constituents in St. John’s Wort: in vitro and in silico investigations. Int J Biol Macromol. 2020;145:620–633.
  • Point V, Pavan Kumar KV, Marc S, et al. Analysis of the discriminative inhibition of mammalian digestive lipases by 3-phenyl substituted 1,3,4-oxadiazol-2(3H)-ones. Eur J Med Chem. 2012;58:452–463.
  • Abousalham A, Verger R. Egg yolk lipoproteins as substrates for lipases. Biochim Biophys Acta. 2000;1485(1):56–62.
  • Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 2007;12(19–20):879–889.
  • George G, S˙n˙c˙ S, Paul AT. Investigation of synergistic potential of green tea polyphenols and orlistat combinations using pancreatic lipase assay-based synergy directed fractionation strategy. S Afr J Bot. 2020;135:50–57.
  • Li S, Pan J, Hu X, et al. Kaempferol inhibits the activity of pancreatic lipase and its synergistic effect with orlistat. J Funct Foods. 2020;72:104041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.